Guru Ownership Trend
Guru Analysis for Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $9.58 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $11.16 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 218.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Zenas BioPharma, Inc. (ZBIO)
Major holders include Steven Cohen ($9.21 M), Cliff Asness ($2.84 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 446,620 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $11.16 M, with 2 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in ZBIO during the most recent reporting period.
Yes, 1 managers opened new positions in ZBIO, and 1 increased their existing holdings. The total reported buy value was $11.16 M.